Marshall Olin is a highly skilled attorney specializing in counseling public and emerging life sciences companies in the areas of intellectual property and business development. Olin has experience working with a range of therapeutic areas and medical devices, including CAR-T therapies, gene therapies, small molecules, antibodies, and oligonucleotide therapies. Throughout his career, Olin has negotiated numerous licensing and distribution arrangements and research, development, and commercialization collaborations. Olin has represented industry clients, non-profit research entities, as well as universities and both public and private hospitals. Olin is passionate about working with his clients to help bring cutting-edge treatments and technologies to market.